In past three months, Sun Pharma had outperformed the market by surging 38% as compared to a 9% rise in the benchmark index till Thursday.
from Latest News https://ift.tt/2Ct9Uqr
Friday, 7 September 2018
Sun Pharma falls 5% on reports of USFDA issues observations
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment